ENDP - 26 year all time low
ENDO has 110B assets, 1.4B cash, 33B sales. In Q1 2022, revenue was 654M alone. It’s trading at a severely undervalued market cap of 141M.
This big pharma company also owns Plan B pill, one of two approved. POTUS has been tweeting about increasing supply to Plan B contraceptives.
ENDO just won an 8 year opioid lawsuit case Friday, July 1st.
Current DCF fair value is $6.59. Likely to be upgraded higher after debt restructuring and potential Plan B deals.
Their pipeline includes 50+ other OTC medications.
This big pharma company also owns Plan B pill, one of two approved. POTUS has been tweeting about increasing supply to Plan B contraceptives.
ENDO just won an 8 year opioid lawsuit case Friday, July 1st.
Current DCF fair value is $6.59. Likely to be upgraded higher after debt restructuring and potential Plan B deals.
Their pipeline includes 50+ other OTC medications.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.